
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Although a contaminant hasn't been found, many dogs continue to become sick from chicken treats imported from China.





